DEF 14A: Exagen Inc. Announces Annual Meeting of Stockholders, Director Nominations, and Auditor Ratification

Exagen Inc. will hold its Annual Meeting of Stockholders on June 10, 2024, to elect directors and ratify the appointment of its independent auditor.

Summary

• Exagen Inc. is holding its Annual Meeting of Stockholders on June 10, 2024, at 6:00 a.m. Pacific Time at the Exagen Administrative Offices in Carlsbad, California.
• Stockholders of record as of April 15, 2024, are entitled to vote.
• The meeting will address the election of three Class II directors for a three-year term expiring at the 2027 Annual Meeting, the ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and any other business that may properly come before the meeting.
• The Board recommends voting for the election of Ana Hooker, Paul Kim, and Frank Stokes as Class II directors and for the ratification of BDO USA, P.C. as the independent auditor.
• Between April 22, 2024 and April 23, 2024, Brian Birk, Wendy Johnson and Ebetual Pallares, Ph.D. notified the Board of each of their decisions to resign as members of the Board, including all committees thereof, effective as of the date of the Annual Meeting.
• On April 25, 2024, upon the recommendation of the Nominating Committee, and pursuant to the bylaws of the Company, the Board appointed, effective as of the date of the Annual Meeting, Scott D. Kahn, Ph.D., to serve as a Class I director.
• Immediately following such resignations and appointment, the size of the Board will be reduced to seven (7) members.
• The company's proxy materials are available online, and stockholders can vote by phone, internet, or mail.
• BDO USA, P.C. has served as Exagen's independent registered public accounting firm since 2017.
• Audit fees billed by BDO USA, P.C. were $581,461 for 2023 and $578,806 for 2022.

Sentiment

Score: 7

Explanation: The document is primarily factual and procedural, outlining the details of the upcoming annual meeting. The tone is professional and informative, with a positive outlook on corporate governance and director qualifications.

Positives

• The Board is actively engaged in corporate governance, with established committees and guidelines.
• Stockholders have multiple options for voting, including phone, internet, and mail.
• The Audit Committee is proactive in overseeing the company's financial reporting and the independence of the auditor.
• The company is committed to environmental sustainability and has implemented practices to reduce energy consumption.
• The company emphasizes diversity and inclusion in its workforce.
• The company offers ongoing training and development, in addition to competitive compensation and benefits packages.

Negatives

• Three directors, Brian Birk, Wendy Johnson and Ebetual Pallares, Ph.D. are resigning from the Board, which could lead to a temporary disruption in board operations.
• The company's stock price has been volatile, which could impact the value of equity-based compensation for executives and directors.
• The company has a history of losses, which could impact its ability to attract and retain talent.

Risks

• The division of the Board into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control of our Company.
• The company's reliance on a single independent registered public accounting firm could pose a risk if the firm were to experience any issues.
• The company's success is reliant upon each individual's significant contribution to our corporate culture and goals, in addition to their commitment to our core company values.

Future Outlook

The company may decide to hold the Annual Meeting in a different location or solely by means of remote communication (i.e., a virtual-only meeting). If the company holds a virtual-only meeting, it will announce the decision to do so in advance, and details on how to participate will be set forth in a press release issued by the company and available on its website.

Management Comments

• John Aballi, President and CEO, expressed gratitude for stockholders' support.
• The Board believes that stockholder ratification of the appointment of BDO USA, P.C. is a good corporate governance practice.

Industry Context

Exagen operates in the diagnostics industry, where companies like Exact Sciences Corporation and Castle Biosciences, Inc. are key players. The election of directors with experience in molecular diagnostics and finance is crucial for Exagen's strategic direction and financial oversight.

Comparison to Industry Standards

• Exagen's audit fees are comparable to those of other diagnostics companies of similar size and complexity.
• The company's director compensation program is in line with industry standards, with a mix of cash retainers and equity awards.
• The company's corporate governance practices are consistent with those of other publicly traded companies in the diagnostics industry.

Management Changes

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process to influence the company's direction.
• Employees may be affected by changes in executive compensation and benefits.
• Customers and suppliers may be impacted by changes in the company's strategic direction.

Next Steps

• Stockholders are urged to vote their shares by phone, internet, or mail.
• The company will announce preliminary voting results at the Annual Meeting and report the final results in a Current Report on Form 8-K.
• The Audit Committee will consider the outcome of the ratification vote when appointing the independent registered public accounting firm for the fiscal year ending December 31, 2024.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Directors, BDO USA, Auditor, Corporate Governance, Stockholders, Election, Ratification, Compensation, Audit Committee, Exagen Inc.